Dr. Ram Yogendra
Appearances
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, well, good seeing you again, Drew. And bye, Susan. And nice meeting you, Elijah. Yeah, this this has taken this is about a four year ordeal. I'll call it an ordeal because it's been it's been taxing and you've been you've been there watching it through. So I know, you know, you've
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
You and I have been in contact over the last four years about this journey that we've gone with our vaccine paper. Started in 2021. Our initial studies were in 2020, looking at post-COVID, many people call it long COVID or PASC. And then as we were studying that, we started to see patients, people coming in with vaccine complications.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Now, initially, we were told that once you get the vaccine, after seven days, maybe 14 days, you might have some symptoms and that'll go away. But then we started having people say, 30 days out, all these symptoms started after I got my first dose, neuropathy, brain fog, fatigue. Um, so a lot of cardiovascular shortness of breath. They are exactly women having menstrual issues.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Uh, they're getting this, you know, they ignored quote unquote gas lit. Uh, we, you know, everyone knows this now, you know, I think it's really now openly talked about, but back in 2021, you said this, you were going to be ostracized, reported to the medical board. possibly lose your privileges credential.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, yeah. So what we found with the vaccine paper was, this is a very specific group of people we studied in 2021.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
um so that's the important thing to keep in mind because i know one of the criticisms and there's going to be a lot of we know we're going to be attacked once this paper comes um yeah and you can see the if you go on my my twitter page i put the whole ordeal that we've had to go through since 2021
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
um basically what we did was we found patients that didn't have covet i screened them with multiple different ways screening methods yeah you know one of the things that you know this criticism is going to come our way is how do you know it that they didn't have covet before well you know what there's no gold standard That is anytime anyone in this space is going to study about the vaccines.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
You know, a couple of months ago, the group in Yale corroborated our findings. They have not published their paper. They put it in a preprint. And the criticism they got was, well, how do you know that it's not COVID? So when I was designing the study, I used many different screening methods. One was the T-detect, the negative PCR, history and physical or history on a patient. And
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And obviously, you know, the history is very important. When you have a patient say, look, I got I have no medical problems. I went and got the vaccine. And 24 hours later, I'm in the emergency room or, you know, I can't get out of bed or having myocarditis and my my chest is about to explode. You know, there is there is definitely something there that needs to be needs to be considered.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah. So everyone knows if you if you find some data, they all say, well, get it in the journals, get it in a in a well-respected, high impact factor medical journal. So he said, OK, you know, we're not going to post stuff on Twitter or, you know, Reddit or wherever people are posting these days. Let's go go through the scientific process and the methodology.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
so in 2021 we by the end of the end of 2021 we had actually found an immune signature in post-covid vaccine syndrome we also found the spike protein from the vaccine in the monocytes in the vascular monocytes of these patients we knew it was the spike protein because we sequenced them so it wasn't just using flow cytometry but we sequenced them and all of this information
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
was on our paper and it's been in the preprint service since 2021 so none of this is new when people say the Yale study was was new it's like no we knew this in 2021 internally in our group we had doctors in our team who told me Rob don't we should not be studying this we should not be looking at this in our own group my God do not put my name on this paper
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And, you know, we have an ethical and moral duty. I'm not making this up. This is not data or something I'm making up. It's just we find something we have to present it to not only the scientific community, but the public, and then let the decision makers decide what they're going to do with that information.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And so that's when we delayed the paper, you know, even submitting it till about the middle of 2020 to the journal. We wanted to get the FDA, the NIH and the CDC engaged.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
now in 2021 april of 2021 we were introduced by congressman mike doyle of pittsburgh to francis collins at the nih and there's this is a public meeting it's on april 29th of 2021 when he was first introduced to all of our research and we sent all of this to dr collins And Congressman Doyle specifically told Dr. Collins to any correspondence with us that he wanted to be CC'd on this.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Well, crickets. We sent all our papers to Dr. Collins. We were on a call with them and he said, oh, this is very interesting. We sent our all our data to the FDA, to Dr. Woodcock, to Dr. Marks, all of our data, what we found. And we were not trying to cause controversy or we say, hey, look, we found something.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
We're finding the spike protein in potentially these in these vaccines weeks and months after after vaccination.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Sure. So we submitted it to six different journals and going through the peer review process. And the first journal said, this is a low priority paper, low priority topic. And that's on my Twitter feed. I posted all of the receipts on there. So anyone that wants to take a look and go see it. One of the other journals said, this is preliminary information.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Finally, one journal said, we will accept for peer review. They came back to me and they said, well, this is all copied from another paper. And I said, well, this is from our paper where we found the spike protein in the long COVID patients. It's the same materials and methods section. And the same journal that had published it, now when it came to the vaccine,
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
they had questions about the materials and methods section. They said, well, you know.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, you know what happens? When you submit a journal, it goes through this plagiarism check, right? So it'll say, oh, 70% of your paper or 80% is plagiarized. Well, we got this thing back saying, well, this entire section is plagiarized. Well, that's because we applied the same exact materials and methods from the long COVID paper. We're the same group that was published the paper.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
So it actually got four out of five stars.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, you know, I think obviously there's a lot of focus right now on Dr. Fauci and his role in COVID and the response to COVID and, you know, with all the stuff going on in Wuhan and the gain-of-function research and all that going on. But I think the role of Dr. Collins here should also be scrutinized. And that's coming from a personal experience because, you know, our work was ignored.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And I don't know the reason why. Maybe he was busy or maybe someone can ask him. But, you know, this is this is not this is public information. This was on a congressional hearing. And I posted this on my Twitter page where Congressman Doyle is literally bringing us up in our research. And we had some correspondence with him.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And then afterwards, we were ghosted, ghosted by the letter organizations by.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
The FDA, NIH, and we didn't engage with the CDC, but it was the NIH and the FDA because we said, look, we found this. I had Brian, he's our lab tech. I said, listen, store the blood because if the FDA scientists or the NIH scientists want to examine these patients' blood, we'll coordinate that and get this over to them. And maybe they can do further studies because
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
You know, quite frankly, even with our research and what we found, there's still a lot of unanswered questions in our findings. So if we had the help back in 2021, I think we might have helped millions of people that have been suffering from these COVID vaccines. It's true.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, so we're trying to get the paper published. Um, now they're hit pieces coming against, uh, Bruce and I, um, we're getting doxed, uh, death threats. Uh, you know, we got, I got a call.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah. Death threats. Um, Bruce got a lot of death threats on his, uh, on his business line at the lab. Uh, people are scared to go to work. You know, some of our credibility is being mirrored all over the place because, you know, quite frankly, we were looking at an uncomfortable topic, and that's the post-COVID vaccine syndrome or the vaccine injuries. So I'm trying to get the paper published.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Multiple journals are rejecting. They're not even letting the paper into peer review, just publicly. But at the same time, we've got this preprint, we're going around discussing this and people are going, well, it's not peer reviewed. Well, I can't get it into peer review because they're not accepting it. And here's the other challenge behind this.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
They'll say, well, you need to get it in a highly respected, high impact factor journal. And now, you know, there's a lot of these predatory journals out there. Unfortunately, many researchers with really good research have to resort to publishing their papers on there because they just don't have an opportunity or a chance to even go through the peer review process.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Then when it does get published, there's a group of, you know, the scientists and researchers that are going to look in and say, well, you publish it in, you know, Bob's international journal of, you know, immunology out of someone's garage. So it completely gets discredited at any of the data. And that is not, not taking, not taken seriously. So that was the challenge that we faced.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah. So we, 2022 trying to get it through 2023 one of the journals said yes but it took us about six months for it to go through peer review because they wrote back to me after six months says we cannot find anyone to peer review the paper
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
no one will we've sent it out to about i would i want to say they said between 20 and 30 of people experts and they said no one they said it's highly unusual that we have this response um but they finally got it through um there were four reviewers one rejected the paper without any comments one refused to review the paper and the other two I'm fully transparent with this information out there.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
So if someone wants to look at my Twitter timeline, I pin this whole ordeal on that. What two other reviewers wrote to us, the reviewer, and gave four out of five stars, said that minor revisions needed and they endorsed it for publication. So Bruce and I are like, well, finally, we're going to get this paper published. And this is August of 2023.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Well, finally, about two weeks later, a specialty editor gets involved and says we are rejecting the paper. And we don't know the reason why. Just said paper is not a fit for the journal. And that was it. And at that point, I was almost two and a half years of just trying to get this to peer review. And to be honest with you, it was just so emotionally taxing. You know, we're self-funded, Bruce.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
I mean, Drew, Bruce and I are self-funded. You know, we don't get any pharma money or government money or anything. We spend our own money on this. And it was just emotionally just draining. I see.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Oh, well, the PTSD is still there. And I'll tell you why.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
I see it.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
So you know what? I didn't know if we were going to ever resubmit the paper again. It's about six journals we went through this. And, you know, when the election happened on November 5th,
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
um something inside of me said you know what maybe things are going to change not just in this country but in the world and maybe we can have some of these difficult conversations and exactly a week later i submitted the paper to a a well a reputable journal um and I said, all right, let's give it a shot. Let's see if the tide has changed. And this was November 12th now.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
I officially submitted the paper back to peer review. Two months later, the journal wrote back to me saying, we are still having a difficulty finding reviewers. In fact, here's the funny thing about this. They sent Bruce Patterson an invitation to peer review our own paper.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
That's how desperate, you know, they just couldn't find a reviewer. But finally we did, we went through the peer review process and about, I think it was April 15th, we got notification that the paper had been accepted for the journal. It was a very vigorous peer review process and it should be, you know, science is all about questioning.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
We're not sitting here with cheerleaders with pom poms and saying, what a great job. It should go through a grueling, rigorous process. The peer review process was about four weeks. I made sure with the rest of my team that the data was immaculate, pristine. All the T's were crossed. Yes, because we know, and even to this day, I talk to the rest of my team, we're so scared.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Of this that someone is going to sabotage his journal like Bruce is just on edge. Everyone on that paper is just on edge, even though we know we've gotten accepted. I just confirmed approved. So I mean, any day now we should we should have the link to the paper. And it is actually, to be honest with you, a much better paper than the preprint version.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
It's significantly better, which is a testament to the peer review process, which is why we need an opportunity to go through the peer review process, which was denied to us for almost four years. But thankfully, and I don't know if it was the tide has changed because of the election and people are able to talk freely. I don't know. I'm merely speculating, but definitely something's changed.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
You know, I think it's a good thing. You know, I think for the longest time, as everyone in medicine knows, some of these high-impact journals out there, these quote-unquote reputable journals, there's a medical oligarchy that's out there that controls the flow and dissemination of information. You're either in the cool crowd or you're outside it. And I think we need to break that up.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
That whole process needs to be dismantled. I'm not necessarily sure anything will come out of this DOJ inquiry because, you know, these journals, it's very easy for them to say, well, you know, that paper or that study wasn't up to the standard of the journal. So I think it might be tough. But what we can do is get more transparency moving forward.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
in how these journals are reviewing articles and papers. For example, it can't just come from some of the elite institutions, because there are some great researchers, as you know, over the years and interviewing other researchers who are not in these big academic centers, they're private investigators.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Absolutely. And like I said, it's a it's a medical oligarchy. Right. So we would get interviewed by by mainstream media, which, by the way, I you know, I get Washington Post and New York Times reporters trying to contact me about our research. And I just kind of give them the Elon respond GFY because, you know, what they'll do is they will they will go.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
They will go and they will interview Bruce and I, get a little quote, and then they'll go to the expert who will then try to discredit us.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And it turns out most of the experts and these people that crapped on us all had conflicts of interest, whether they were paid by pharma, which if you go to openpayments.gov, you can look and see who's been paid by pharma, or they have some sort of competing interests between a lab or some research that they're trying to do.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, so we've actually got, so we're doing a, the FDA has approved a clinical trial with long COVID, which is studying the spike proteins and the vascular monocytes from the COVID infection. We actually have congressional support.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Well, we're going to do both. So right now, what we're working on is Senator Todd Young has really been a big supporter of us, and he's helping us with Congressman Pete Stauber in Minnesota and Congressman Jeff Crank in Colorado.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
who are just running up and down the halls of uh in dc uh trying to help us right now which is uh which is incredible and i know a lot of people saw uh senator young uh with the rfk confirmation and he's been really a big uh advocate for the the long covet community and which was a testament because one of the things i want to mention is that you know this whole there's a whole division an argument about long covet and long backs and it's
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Sort of a right wing versus left. And we've got a lot of support from from the GOP side. And I keep telling people this long COVID is not a left wing liberal disease. You know, this is this is something. You're right, this is something actually GOP, we've got more congressional Republican senators and congressmen behind us than unfortunately our Democrat side and shouldn't be political.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
So we got an FDA approved clinical study that we're trying to get funding to and hopefully we should have, we've got a couple of leads that Senator Young is working on. Now that this paper- This is for treatment?
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, it's a morale bracket. Marabara, ketorvastatin, phase three FDA approved clinical trial that in 16 weeks if the trial is successful, we'll have the first approved medication for long COVID. And what I've done, I've actually just finished writing the protocol now that our vaccine paper is published, is a phase three clinical trial for post COVID vaccine syndrome.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
which we're submitting to the FDA in about a week, and then hopefully get funding to run. Is that a different protocol? It's a different protocol. Yep, that's a different protocol we're going to submit to the FDA.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, again, it's the same thing. It's a Mirovac and a statin combination, but the patient population is going to be different. We're going to look at vaccine-injured patients and then screen them one year not having a COVID infection. You know, here's the thing, Drew, that's difficult about studying the vaccine group right now because many of them got COVID afterwards, so it sort of muddies up.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
That the argument could be made as well, is this because of COVID or is this because of the vaccine?
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
That's what we're doing. So what we're doing is we're saying if you had a vaccine injury, a documented vaccine injury, regardless of the time period, and you haven't had a COVID infection in the past year, you're enrolled in the study. When the paper comes out, you'll see there are different immune markers with the vaccine group compared to the COVID group.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
But right now, if you're trying to study this, it's going to be a mix because people that had vaccine injuries got COVID, and it's a big mishmash of things right now.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
yeah so that's so that's the next thing you know i think the focus should be you know there's a lot of anything rightfully so discussions on the code uh the vaccines and the mandates and all of that that's going on but i think a lot of discussion needs to be made but we need to have more discussion with running clinical trials and get therapeutics you know i've been reading some some articles and and speculation that
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
We're looking at about maybe 15 to 20 vaccine-injured patients in the United States, along with another 20 million or more that have long COVID. So if you take those numbers, you're looking at about 40 million, 50 million Americans that have COVID. long COVID or backs injured, you know, we're looking at about 15, 20% of the American population.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
So, you know, and, and, you know, instead of looking maybe back and trying to point fingers, I, I'm more focused on looking forward and saying, how can we helping people helping, right?
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, you know what's really interesting? Some of these long COVID patients and even the vaccine-injured patients, what we're doing is we're actually finding also Lyme in them too. So we're finding reactivated herpes infections. The Yale study found that some of these vaccine-injured patients had low CD4 counts. There's some sort of immunosuppression taking place.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And with our long COVID patients, we saw CD8 counts that are low.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Yeah, I've seen that, you know, in fact, we have in our Vax paper, there is a potential, you know, a signal there with some of the immune markers, um, that might be that, that are sort of tumor checkpoints, um, that, that regulate the checkpoints and tumor, um, in angiogenesis. So. You know, I think there's a lot more to uncover with that spike protein and what was injected in people.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And we just need to have those uncomfortable conversations. The other thing, too, I just want to mention, Drew, that we can't study long COVID without acknowledging the vaccine, injured patients. Yeah. Congress has given $1.6 billion to the NIH, and no one knows where this money has gone. Stat News and Washington Post have been writing articles about this.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
The congressmen that we talked to are just frustrated. They said, well, where is this money gone? And if you look at the research that's going in long COVID – and I hope Dr. Bhattacharya and Bobby Kennedy look into this – Hey, how are we spending this money on long COVID? Because they're just going around in circles, like no one is acknowledging the vaccine injured.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
And you have to include them if you're going to study long COVID, otherwise we're wasting US taxpayer dollars. And quite frankly, you're not seeing anything meaningful coming out of that $1.6 billion that have been allocated by Congress.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
I post on X, Dr. Yostradamus on X. I post all my papers there. And in the next couple of days, we should have the vaccine paper on there. And then we post updates on all the work that we're doing with our research with long COVID and the vaccine studies. And hopefully in the And next couple of weeks, we'll get a green light from the FDA on a vaccine clinical trial.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
So we try to get some help for these patients out there.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Absolutely. Clinical trials. Let's, you know, we got all this money rather than funding. I don't know what, what they're funding this money for. You know, one of the, you know, one of the studies they were looking at was kimchi, uh, One of the studies that was allocated from the NIH RECOVER trial to study long COVID was Kim Chi. I remember looking at this going, are you kidding me?
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
So we need some oversight and some deep dive into how this money has been spent. And just like you said, Drew, there's some really interesting stuff there, colchicine, the anticoagulants, and let's get some clinical trials and some data out there that we can make some meaningful impact in people's lives.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
Drew, you and Susan have been, I mean, so instrumental and supportive, especially times when I would text you and say, Drew, you know, F this, I can't do this. And you just, you and Susan were awesome in, you know, helping me push through. You were on dose of Dr. Drew.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
He just got part of it. I think a lot of us did. Yeah.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
But a lot of us did, Drew. We believe in our institutions, and then now we're questioning everything, not only from COVID, but what we've been taught in med school in the last several decades.
Ask Dr. Drew
DOJ Investigating Medical Journals For Fraud; Publishers Call Letters “Harassment” w/ Elijah Schaffer & Dr. Ram Yogendra – Ask Dr. Drew – Ep 481
I will. Thanks, Drew. Thanks, Susan. Appreciate the support.